New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
06:51 EDTCBRX, ACTColumbia Laboratories repurchases 1.4M shares of common stock from Actavis
Columbia Laboratories (CBRX) announced that the company has repurchased 1.4 million shares of its common stock, par value 1c per share, from Coventry Acquisition, a subsidiary of Actavis (ACT) at $6.08 per share, which represents a 10.75% discount to the closing price on March 6. The total purchase price was approximately $8.5M. This transaction reduces the total issued and outstanding shares of common stock by about 11.5% from approximately 12.15M to 10.75M.
News For CBRX;ACT From The Last 14 Days
Check below for free stories on CBRX;ACT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2014
10:02 EDTACTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTACTDeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:09 EDTACTActavis initiated with a Buy at Deutsche Bank
Subscribe for More Information
July 21, 2014
16:36 EDTACTActavis and Medicines360 announce FDA acceptance of Levosert NDA
Subscribe for More Information
July 17, 2014
15:42 EDTACTDepomed says Actavis preliminarily enjoined from marketing generic Gralise
Subscribe for More Information
08:34 EDTCBRXColumbia Laboratories awarded U.S. patent for hydration tablets
Subscribe for More Information
July 16, 2014
11:28 EDTACTLeon Cooperman gives 12 stock picks at CNBC conference
Subscribe for More Information
11:16 EDTACTCooperman lists Actavis, Citigroup, KKR among top-picks, CNBC says
Subscribe for More Information
09:12 EDTACTLeerink healthcare analyst holds an analyst/industry conference call
Subscribe for More Information
July 11, 2014
16:31 EDTACTActavis confirms generic Diclegis patent challenge
Subscribe for More Information
July 9, 2014
06:49 EDTACTGeneric drug prices have risen significantly, NY Times says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use